CLINICAL_TRIALS
trial_result
· 2020-10-19
Clinical Trial Update: Study to Evaluate the Efficacy of HepaStem in Urea Cycle Disorders Paediatric Patients (HEP002) [Phase 2]
Summary
Phase 2 clinical trial evaluating the efficacy of HepaStem in paediatric patients with urea cycle disorders has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cellaion SA | Conditions: Urea Cycle Disorders | Phase 2 | Status: COMPLETED